Latest News about Perception NeuroscienceRecent news which mentions Perception Neuroscience
Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration
August 09, 2023
From Benzinga
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges
January 06, 2023
Tickers
ATAI
From Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
October 26, 2022
Tickers
ATAI
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|
Latest News about Perception NeuroscienceRecent news which mentions Perception Neuroscience
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |